Project Talimogene Laherparepvec T-VEC 20110265

Basic data

Title:
Talimogene Laherparepvec T-VEC 20110265
Duration:
01/06/2016 to 31/12/2019
Abstract / short description:
Protokoll 20110265: Multizentrische, offene Studie der Phase 1b/3 mit Talimogene Laherparepvec in Kombination mit Pembrolizumab (MK-3475) zur Behandlung des nicht resezierten Melanoms im Stadium IIIB bis IVM1c (MASTERKEY-265)
Keywords:
melanoma
Melanom

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

München, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.